Results 11 to 20 of about 9,624 (181)
A multiomics disease progression signature of low-risk ccRCC [PDF]
Scientific Reports, 2022 Clear cell renal cell carcinoma (ccRCC) is the most common renal cancer. Identification of ccRCC likely to progress, despite an apparent low risk at the time of surgery, represents a key clinical issue. From a cohort of adult ccRCC patients (n = 443), we
Sigrid Nakken +26 more
core +7 more sources
Cuproptosis in ccRCC: key player in therapeutic and prognostic targets [PDF]
Frontiers in Oncology, 2023 BackgroundClassical biomarkers have been used to classify clear cell renal cell carcinoma (ccRCC) patients in a variety of ways, and emerging evidences have indicated that cuproptosis is closely related to mitochondrial metabolism, thereby accelerating ...
Chao Qin +6 more
core +4 more sources
ccRCC is fundamentally a metabolic disorder [PDF]
Cell Cycle, 2014 Clear cell renal-cell carcinoma (ccRCC) represents the most common RCC subtype, being exceptionally resistant to therapy and responding poorly to radiotherapy, hormonal therapy and chemotherapy1; t...
Zaravinos, Apostolos +3 more
openaire +3 more sources
Multivariate analysis of overall survival in 526 ccRCC patients.
, 2022 Multivariate analysis of overall survival in 526 ccRCC patients.
Tie Chong (655561) +8 more
core +4 more sources
ccRCC proteome quantification matrix
, 2021 ccRCC proteome quantification ...
Jinwen Feng (11829878)
core +1 more source
MT1X is an oncogene and indicates prognosis in ccRCC
Bioscience Reports, 2022 Abstract The metallothionein 1 (MT1) family was previously shown to be involved in metal ion homeostasis, DNA damage, oxidative stress, and carcinogenesis. Our team’s previous study showed that MT1X is most closely associated with ccRCC. However, its role in clear cell RCC (ccRCC) remains unclear.
Yanpeng Ding +9 more
openaire +2 more sources
Expression of PLAUR in ccRCC and methylation study.
, 2022 A-F. Analysis of PLAUR expression and prognosis in ccRCC; G-J. Analysis of methylation levels and prognostic correlation of PLAUR in ccRCC.
Zengshu Xing (12837293) +4 more
core +1 more source
Basic characteristics of 526 ccRCC patients.
, 2022 Basic characteristics of 526 ccRCC patients.
Tie Chong (655561) +8 more
core +1 more source
SDHB Suppresses the Tumorigenesis and Development of ccRCC by Inhibiting Glycolysis [PDF]
Frontiers in Oncology, 2021 Metabolic reprogramming is the prominent feature of clear cell renal cell carcinoma (ccRCC). Succinate dehydrogenase subunit B (SDHB) is one of subunits of mitochondrial respiratory chain complex II. The loss of SDHB function is closely related with metabolic changes in kidney cancer cells.
Zhiyu Fang +3 more
openaire +3 more sources
Frontiers in Immunology, 2022 Unlike early clear cell renal cell carcinoma (ccRCC), locally advanced and metastatic ccRCC present poor treatment outcomes and prognosis. As immune checkpoint inhibitors have achieved favorable results in the adjuvant treatment of metastatic ccRCC, we ...
Enyu Lin +14 more
doaj +1 more source